{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,9,7]],"date-time":"2023-09-07T09:09:19Z","timestamp":1694077759737},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2015,11,21]],"date-time":"2015-11-21T00:00:00Z","timestamp":1448064000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Internist"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s00108-015-3755-3","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T11:40:22Z","timestamp":1447933222000},"page":"1369-1378","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Therapie des Pruritus bei inneren Erkrankungen"],"prefix":"10.1007","volume":"56","author":[{"given":"T.","family":"Mettang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"St\u00e4nder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.E.","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,11,21]]},"reference":[{"key":"3755_CR1","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.revmed.2003.12.015","volume":"25","author":"Afifi","year":"2004","unstructured":"Afifi Y, Aubin F, Puzenat E et\u00a0al (2004) Enqu\u00eate \u00e9tiologique d\u2019un prurit sine materia: \u00e9tude prospective d\u2019une s\u00e9rie de 95\u00a0patients [Pruritus sine materia: a prospective study of 95\u00a0patients]. Rev Med Interne 25(7):490\u2013493","journal-title":"Rev Med Interne"},{"key":"3755_CR2","first-page":"619","volume":"J","author":"Diehn","year":"2001","unstructured":"Diehn F, Tefferi A (2001) Pruritus in polycythaemia vera: prevalence, laboratory correlates and management. Br\u00a0J Haematol 115(3):619\u2013621","journal-title":"Br"},{"key":"3755_CR3","doi-asserted-by":"crossref","unstructured":"Duque MI, Yosipovitch G, Fleischer AB et\u00a0al (2005) Lack of efficacy of tacrolimus ointment 0.1\u2009% for treatment of hemodialysis-related pruritus: a randomized, double-blind, vehicle-controlled study. J\u00a0Am Acad Dermatol 52(3 Pt\u00a01):519\u2013521","DOI":"10.1016\/j.jaad.2004.08.050"},{"key":"3755_CR4","doi-asserted-by":"crossref","first-page":"17","DOI":"10.7326\/0003-4819-91-1-17","volume":"91","author":"Gilchrest","year":"1979","unstructured":"Gilchrest BA, Rowe JW, Brown RS et\u00a0al (1979) Ultraviolet phototherapy of uremic pruritus. Long-term results and possible mechanism of action. Ann Intern Med 91(1):17\u201321","journal-title":"Ann Intern Med"},{"key":"3755_CR5","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1093\/ndt\/gfh496","volume":"19","author":"Gunal","year":"2004","unstructured":"Gunal AI, Ozalp G, Yoldas TK et\u00a0al (2004) Gabapentin therapy for pruritus in haemodialysis patients. A randomized, placebo-controlled, double-blind trial. Nephrol Dial Transplant 19(12):3137\u20133139","journal-title":"Nephrol Dial Transplant"},{"key":"3755_CR6","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.2165\/00003495-200868150-00006","volume":"68","author":"Kremer","year":"2008","unstructured":"Kremer AE, Beuers U, Oude-Elferink RPJ et\u00a0al (2008) Pathogenesis and treatment of pruritus in cholestasis. Drugs 68(15):2163\u20132182","journal-title":"Drugs"},{"key":"3755_CR7","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1053\/j.gastro.2010.05.009","volume":"139","author":"Kremer","year":"2010","unstructured":"Kremer AE, Martens JJ, Kulik W et\u00a0al (2010) Lysophosphatidic acid is a potential mediator of cholestatic pruritus. Gastroenterology 139(3):1008\u20131018, 1018.e1","journal-title":"Gastroenterology"},{"key":"3755_CR8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.clinre.2010.10.007","volume":"35","author":"Kremer","year":"2011","unstructured":"Kremer AE, Oude Elferink RP, Beuers U (2011) Pathophysiology and current management of pruritus in liver disease. Clin Res Hepatol Gastroenterol 35(2):89\u201397","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"3755_CR9","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/hep.23821","volume":"52","author":"Kuiper","year":"2010","unstructured":"Kuiper EM, Erpecum KJ van, Beuers U et\u00a0al (2010) The potent bile acid sequestrant colesevelam is not effective in cholestatic pruritus: results of a double-blind, randomized, placebo-controlled trial. Hepatology 52(4):1334\u20131340","journal-title":"Hepatology"},{"key":"3755_CR10","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/ndt\/gfp588","volume":"25","author":"Kumagai","year":"2010","unstructured":"Kumagai H, Ebata T, Takamori K et\u00a0al (2010) Effect of a novel kappa-receptor agonist, nalfurafine hydrochloride, on severe itch in 337\u00a0haemodialysis patients. A Phase\u00a0III, randomized, double-blind, placebo-controlled study. Nephrol Dial Transplant 25(4):1251\u20131257","journal-title":"Nephrol Dial Transplant"},{"key":"3755_CR11","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1093\/ndt\/gfh202","volume":"19","author":"Kuypers","year":"2004","unstructured":"Kuypers DR, Claes K, Evenepoel P et\u00a0al (2004) A prospective proof of concept study of the efficacy of tacrolimus ointment on uraemic pruritus (UP) in patients on chronic dialysis therapy. Nephrol Dial Transplant 19(7):1895\u20131901","journal-title":"Nephrol Dial Transplant"},{"key":"3755_CR12","first-page":"137","volume":"4","author":"Makhlough","year":"2010","unstructured":"Makhlough A, Ala S, Haj-Heydari Z et\u00a0al (2010) Topical capsaicin therapy for uremic pruritus in patients on hemodialysis. Iran J Kidney Dis 4(2):137\u2013140","journal-title":"Iran J Kidney Dis"},{"key":"3755_CR13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1002\/hep.21553","volume":"45","author":"Mayo","year":"2007","unstructured":"Mayo MJ, Handem I, Saldana S et\u00a0al (2007) Sertraline as a first-line treatment for cholestatic pruritus. Hepatology 45(3):666\u2013674","journal-title":"Hepatology"},{"key":"3755_CR14","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/ki.2013.454","volume":"87","author":"Mettang","year":"2015","unstructured":"Mettang T, Kremer AE (2015) Uremic pruritus. Kidney Int 87(4):685\u2013691","journal-title":"Kidney Int"},{"key":"3755_CR15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00105-014-2755-x","volume":"65","author":"Mettang","year":"2014","unstructured":"Mettang T, Vonend A, Raap U (2014) Prurigo nodularis bei Dermatosen und systemischen Erkrankungen. Hautarzt 65(8):697\u2013703","journal-title":"Hautarzt"},{"key":"3755_CR16","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1177\/089686080002000641","volume":"20","author":"Pauli-Magnus","year":"2000","unstructured":"Pauli-Magnus C, Klumpp S, Alscher DM et\u00a0al (2000) Short-term efficacy of tacrolimus ointment in severe uremic pruritus. Perit Dial Int 20(6):802\u2013803","journal-title":"Perit Dial Int"},{"key":"3755_CR17","doi-asserted-by":"crossref","unstructured":"Pauli-Magnus C, Mikus G, Alscher DM et\u00a0al (2000) Naltrexone does not relieve uremic pruritus: results of a randomized, double-blind, placebo-controlled crossover study. J\u00a0Am Soc Nephrol 11(3):514\u2013519","DOI":"10.1681\/ASN.V113514"},{"key":"3755_CR18","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/S0140-6736(96)04176-1","volume":"348","author":"Peer","year":"1996","unstructured":"Peer G, Kivity S, Agami O et\u00a0al (1996) Randomised crossover trial of naltrexone in uraemic pruritus. Lancet 348(9041):1552\u20131554","journal-title":"Lancet"},{"key":"3755_CR19","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1080\/08860220802595476","volume":"31","author":"Razeghi","year":"2009","unstructured":"Razeghi E, Eskandari D, Ganji MR et\u00a0al (2009) Gabapentin and uremic pruritus in hemodialysis patients. Ren Fail 31(2):85\u201390","journal-title":"Ren Fail"},{"key":"3755_CR20","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000187978","volume":"67","author":"Silva","year":"1994","unstructured":"Silva SR, Viana PC, Lugon NV et\u00a0al (1994) Thalidomide for the treatment of uremic pruritus. A crossover randomized double-blind trial. Nephron 67(3):270\u2013273","journal-title":"Nephron"},{"key":"3755_CR21","doi-asserted-by":"crossref","unstructured":"Tan JK, Haberman HF, Coldman AJ (1991) Identifying effective treatments for uremic pruritus. J\u00a0Am Acad Dermatol 25(5 Pt\u00a01):811\u2013818","DOI":"10.1016\/S0190-9622(08)80975-9"},{"key":"3755_CR22","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1111\/j.1572-0241.2007.01200.x","volume":"102","author":"Tandon","year":"2007","unstructured":"Tandon P, Rowe BH, Vandermeer B et\u00a0al (2007) The efficacy and safety of bile acid binding agents, opioid antagonists, or rifampin in the treatment of cholestasis-associated pruritus. Am J Gastroenterol 102(7):1528\u20131536","journal-title":"Am J Gastroenterol"},{"key":"3755_CR23","doi-asserted-by":"crossref","unstructured":"Tsochatzis EA, Gurusamy KS, Gluud C et\u00a0al (2009) Ursodeoxycholic acid and primary biliary cirrhosis: EASL and AASLD guidelines. J\u00a0Hepatol 51(6):1084\u20131085","DOI":"10.1016\/j.jhep.2009.09.015"},{"key":"3755_CR24","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.ejphar.2003.08.007","volume":"477","author":"Umeuchi","year":"2003","unstructured":"Umeuchi H, Togashi Y, Honda T et\u00a0al (2003) Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system. Eur J Pharmacol 477(1):29\u201335","journal-title":"Eur J Pharmacol"},{"key":"3755_CR25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1002\/cncr.28441","volume":"120","author":"Verstovsek","year":"2014","unstructured":"Verstovsek S, Passamonti F, Rambaldi A et\u00a0al (2014) A phase\u00a02 study of ruxolitinib, an oral JAK1 and JAK2 inhibitor, in patients with advanced polycythemia vera who are refractory or intolerant to hydroxyurea. Cancer 120(4):513\u2013520","journal-title":"Cancer"},{"key":"3755_CR26","doi-asserted-by":"crossref","first-page":"816","DOI":"10.2340\/00015555-2023","volume":"95","author":"Weiss","year":"2015","unstructured":"Weiss M, Mettang T, Tschulena U et\u00a0al (2015) Prevalence of chronic itch and associated factors in haemodialysis patients: a representative cross-sectional study. Acta Derm Venereol 95(7):816\u2013821","journal-title":"Acta Derm Venereol"},{"key":"3755_CR27","doi-asserted-by":"crossref","unstructured":"Wikstrom B, Gellert R, Ladefoged SD et\u00a0al (2005) Kappa-opioid system in uremic pruritus. Multicenter, randomized, double-blind, placebo-controlled clinical studies. J\u00a0Am Soc Nephrol 16(12):3742\u20133747","DOI":"10.1681\/ASN.2005020152"},{"key":"3755_CR28","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s11255-014-0795-x","volume":"47","author":"Yue","year":"2015","unstructured":"Yue J, Jiao S, Xiao Y et\u00a0al (2015) Comparison of pregabalin with ondansetron in treatment of uraemic pruritus in dialysis patients: a prospective, randomized, double-blind study. Int Urol Nephrol 47(1):161\u2013167","journal-title":"Int Urol Nephrol"}],"container-title":["Der Internist"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3755-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00108-015-3755-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00108-015-3755-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,26]],"date-time":"2022-05-26T15:58:18Z","timestamp":1653580698000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00108-015-3755-3"}},"subtitle":["Was ist gesichert?"],"short-title":[],"issued":{"date-parts":[[2015,11,21]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["3755"],"URL":"https:\/\/doi.org\/10.1007\/s00108-015-3755-3","relation":{},"ISSN":["0020-9554","1432-1289"],"issn-type":[{"value":"0020-9554","type":"print"},{"value":"1432-1289","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,11,21]]}}}